Connection

Beth Bell to Adverse Drug Reaction Reporting Systems

Back to Details
This is a "connection" page, showing publications Beth Bell has written about Adverse Drug Reaction Reporting Systems.
Beth Bell
Connection Strength
0.151
Adverse Drug Reaction Reporting Systems
  1. Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021. MMWR Morb Mortal Wkly Rep. 2021 Apr 30; 70(17):651-656.
    View in: PubMed
    Score: 0.038
  2. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Janssen COVID-19 Vaccine - United States, February 2021. MMWR Morb Mortal Wkly Rep. 2021 03 05; 70(9):329-332.
    View in: PubMed
    Score: 0.038
  3. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Moderna COVID-19 Vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2021 Jan 01; 69(5152):1653-1656.
    View in: PubMed
    Score: 0.037
  4. The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine - United States, December 2020. MMWR Morb Mortal Wkly Rep. 2020 Dec 18; 69(50):1922-1924.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.